TITLE

Ontario: the revolutionary vanguard?

AUTHOR(S)
Schuster, Eli
PUB. DATE
May 2001
SOURCE
Report / Newsmagazine (National Edition);05/28/2001, Vol. 28 Issue 11, p20
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Considers the possibility of increasing the private-sector presence in medicare in Canada. Increase in the Ontario government's spending on medicare; Factors perceived to be responsible for Canada's rising healthcare costs; Characterization of medicare as a monopoly provider; Opinion that considering private healthcare is a risky short-term political strategy for the provinces.
ACCESSION #
4492537

 

Related Articles

  • Ontario: the revolutionary vanguard? Schuster, Eli // Report / Newsmagazine (Alberta Edition);05/28/2001, Vol. 28 Issue 11, p20 

    Considers the possibility of increasing the private-sector presence in medicare in Canada. Increase in the Ontario government's spending on medicare; Factors perceived to be responsible for Canada's rising healthcare costs; Characterization of medicare as a monopoly provider; Opinion that...

  • Ontario: the revolutionary vanguard? Schuster, Eli // Report / Newsmagazine (BC Edition);05/28/2001, Vol. 28 Issue 11, p20 

    Considers the possibility of increasing the private-sector presence in medicare in Canada. Increase in the Ontario government's spending on medicare; Factors perceived to be responsible for Canada's rising healthcare costs; Characterization of medicare as a monopoly provider; Opinion that...

  • Health care reforms we can all agree on. Donohue, Thomas J. // Business Journal Serving Fresno & the Central San Joaquin Valley;3/13/2009, Issue 323996, p26 

    In this article the author reflects on the impact of the proposed reform of the U.S. health care system on employers and businesses. He asserts that the employer community has been at the center of the country's health care system for decades and this sector is more greatly impacted by the...

  • Value-Based Insurance Design. Chernew, Michael E.; Rosen, Allison B.; Fendrick, A. Mark // Health Affairs;2007 Supplement, Vol. 26, pw195 

    When everyone is required to pay the same out-of-pocket amount for health care services whose benefits depend on patient characteristics, there is enormous potential for both under- and overuse. Unlike most current health plan designs, Value-Based Insurance Design (VBID) explicitly acknowledges...

  • (HEALTH REFORM) Progressive Advocates Push for Public Plan.  // Aging News Alert;8/7/2009, p2 

    The article reports on the finalization of the health reform bill in the U.S. It notes that the fundamental aim of such reform is to contain health care cost, to improve quality and to drive value. Moreover, an analysts at the liberal-oriented Campaign for America's Future (CAF) suggests that...

  • Five Principles For Health-Care Reform. Donohue, Thomas J. // Business Journal (Central New York);12/7/2007, Vol. 21 Issue 49, p26 

    The article discusses the principles of health care reform in the U.S. The author mentions that the U.S. is home to some of the finest medical facilities, technologies, innovations, treatments and human talent. He suggests five core ideas that can guide the nation to more affordable and...

  • Not cost-effective by design. LEVIN, ALAN J. // Medical Economics;12/10/2011, Vol. 88 Issue 23, p98 

    The article presents the author's opinion on healthcare financing reform. The author shows concern on how much healthcare is sufficient for a person to buy. The author says that the healthcare system after the Second World War had enough resources to pay for anything any patient might need. The...

  • Managed care as savior. BENSON, BARBARA // Crain's New York Business;1/31/2011, Vol. 27 Issue 5, p2 

    The article focuses on the growing need of reforming medicaid system in New York. According to a report, about 1 million people account for 20% of the people enrolled, in New York in Medicaid's special-needs population but 75% of the spending. It is suggested that reforming Medicaid has the...

  • Value-Based Pricing. Miller, David W. // Pharmaceutical Medicine - New Zealand;2012, Vol. 26 Issue 4, p217 

    Rising costs in healthcare mean that many countries can no longer absorb the increased expenses associated with innovative yet expensive new medicines. Innovation and investment in research and development (R&D) have become secondary factors to cash-strapped governments looking to control...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics